3BIGS utilizes bio big data and AI-driven platforms to analyze next-generation sequencing (NGS) data, identifying patterns, mutations, and biomarkers for drug discovery and healthcare insights. The company addresses the challenge of extracting actionable information from vast biological datasets, accelerating the development of targeted therapies and improving patient outcomes.
Funding
$2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The analysis of next-generation sequencing (NGS) data to identify patterns, mutations, and biomarkers is challenging due to the vast amount of data and the complexity of biological systems. Extracting actionable insights from these datasets is a bottleneck in drug discovery and the development of targeted therapies.
Solution
3BIGS provides AI-driven platforms for analyzing bio big data, specifically NGS data, to accelerate drug discovery and improve healthcare outcomes. Their solutions enable the identification of patterns, mutations, and biomarkers within complex biological datasets. By leveraging AI and machine learning, 3BIGS helps researchers and healthcare professionals extract meaningful information from omics data, facilitating the development of targeted therapies and personalized medicine approaches. The company offers a suite of tools for data integration, analysis, and knowledge mining, streamlining the process of translating raw data into actionable insights.
Target Audience
The primary target audience includes researchers, pharmaceutical companies, and healthcare organizations involved in drug discovery, genomics, proteomics, and personalized medicine.
Features
- **3X-TMiner:** A literature survey and mining platform for structuring information from scientific articles.
- **3X-KBank:** An integration platform to collect, refine, and integrate biodata into various databases.
- **3X-MOmics:** A multi-omics analysis platform to analyze diverse NGS-based biodata.
- NGS data analysis to reveal patterns, mutations, and biomarkers.
- Sequence-Based Virtual Screening (SBVS) to accelerate drug discovery.
- AI/ML integrated solutions for predictive analytics in genomics and proteomics.
- Customized software solutions for bioinformatics analysis.